GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Psyence Group Inc (XCNQ:PSYG) » Definitions » Total Current Liabilities

Psyence Group (XCNQ:PSYG) Total Current Liabilities : C$3.35 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Psyence Group Total Current Liabilities?

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Psyence Group's total current liabilities for the quarter that ended in Sep. 2024 was C$3.35


Psyence Group Total Current Liabilities Historical Data

The historical data trend for Psyence Group's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Group Total Current Liabilities Chart

Psyence Group Annual Data
Trend Dec19 Dec20 Mar22 Mar23 Mar24
Total Current Liabilities
0.06 0.14 1.59 2.62 15.07

Psyence Group Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.38 1.37 15.07 10.30 3.35

Psyence Group Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Psyence Group's Total Current Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=1.223+12.374
+Other Current Liabilities+Current Deferred Liabilities
=1.476+0
=15.07

Psyence Group's Total Current Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=1.339+1.756
+Other Current Liabilities+Current Deferred Liabilities
=0.254+0
=3.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.


Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term


Psyence Group Total Current Liabilities Related Terms

Thank you for viewing the detailed overview of Psyence Group's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Psyence Group Business Description

Traded in Other Exchanges
Address
121 Richmond Street West, Penthouse Suite, 1300, Toronto, ON, CAN, M5H 2K1
Psyence Group Inc is a life science biotechnology company focused on the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma in the context of palliative care and in support of mental wellness.
Executives
Jody Aufrichtig Director, Senior Officer
Warwick Corden-lloyd Senior Officer
Neil Maresky Senior Officer

Psyence Group Headlines

No Headlines